Functional VEGF and VEGF receptors are expressed in human medulloblastomas

Neuro-Oncology

Volumn 9, Issue 4, 2007, Pages 384-392

  Slongo, M Liliana ^a   Molena, Beatrice ^a   Brunati, Anna Maria ^a   Frasson, Martina ^a   Gardiman, Marina ^a   Carli, Modesto ^b   Perilongo, Giorgio ^b   Rosolen, Angelo ^b   Onisto, Maurizio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Medulloblastoma; VEGF; VEGFRs

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADOLESCENT; BIOSYNTHESIS; CEREBELLUM TUMOR; CHILD; FEMALE; GENE EXPRESSION; MALE; METABOLISM; PRESCHOOL CHILD; TUMOR CELL LINE;

ADOLESCENT; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEDULLOBLASTOMA; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35648956157     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2007-032     Document Type: Article

References (32)

1. Gilbertson RJ. Medulloblastoma: signalling a change in treatment. Lancet Oncol. 2004;5:209-218.
2. Rood BR, Macdonald TJ, Packer RJ. Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol. 2004;31:666-675.
3. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
4. Ozer E, Sarialioglu F, Cetingoz R, et al. Prognostic significance of ana-plasia and angiogenesis in childhood medulloblastoma: a Pediatric Oncology Group study. Pathol Res Pract. 2004;200:501-509.
5. Huber H, Eggert A, Janss AJ, et al. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. Eur J Cancer. 2001;37:2064-2072.
6. Bjerkvig R, Lund-Johansen M, Edvardsen K. Tumor cell invasion and angiogenesis in the central nervous system. Curr Opin Oncol. 1997; 9:223-229.
7. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumour growth and angiogenesis. J Clin Oncol. 2005; 23:1011-1027.
8. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438:967-974.
9. Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 1999;59:728-733.
10. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine factor for VEGF receptor-positive human tumours. Blood. 2001;98:1904-1913.
11. Lacal PM, Failla CM, Pagani E, et al. Human melanoma cells secrete and respond to placenta growth factor and vascu lar endothelial growth factor. J Invest Dermatol. 2000;115:1000-1007.
12. Ferrer FA, Miller LJ, Lindquist R, et al. Expression of vascular endo-thelial growth factor receptors in human prostate cancer. Urology. 1999;54:567-572.
13. Dias S, Hattori K, Zhu Z, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest. 2000;106:511-521.
14. Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene. 2005;24:8025-8037.
15. Steiner H-H, Karcher S, Muller MM, Nalbantis E, Kunze S, Herold-Mende C. Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiform: clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol. 2004; 66:129-138.
16. Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int J Oncol. 2005;27:791-798.
17. Yamagata A, Kristensen DB, Takeda Y, et al. Mapping of phosphory-lated proteins on two-dimensional polyacrylamide gels using protein phosphatase. Proteomics. 2002;2:1267-1276.
18. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-985.
19. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
20. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med. 2005;9:777-794.
21. Dias S, Hattori K, Heissig B, et al. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signalling pathways is essential to inducing long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA. 2001;98:10857-10862.
22. Gorski DH, Beckett MA, Jaskowiak NT, et al. Blockage of the vascular endothelial growth factor stress response increases the anti-tumour effects of ionizing radiation. Cancer Res. 1999;59:3374-3378.
23. Huh JI, Calvo A, Stafford J, et al. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Onco-gene. 2005;24:790-800.
24. He X, Skapek SX, Wikstrand CJ, et al. Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts. J Neuropath Exp Neurol. 1989;48:48-68.
25. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676.
26. Herold-Mende C, Steiner HH, Andl T, et al. Expression and functional significance of vascular endothelial growth factor receptors in human tumour cells. Lab Invest. 1999;79:1573-1582.
27. Chen G, Gharib TG, Huang C-C, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics. 2002; 1:304-313.
28. Bagnard D, Vaillant C, Khuth S-T, et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apop-tosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci. 2001;21:3332-3341.
29. Binetruy-Tournaire R, Demangel C, Malavaud B, et al. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 2000;19:1525-1533.
30. Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signalling of breast cancer cells. Cell Growth Differ. 2001;12:129-135.
31. Wey JS, Fan F, Gray MJ, et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. 2005;104;427-438.
32. Sebolt-Leopold JS, English JM. Mechanisms of drug inhibition of signalling molecules. Nature. 2006;441:457-462.